Using sampling “windows” for PK blood samples [Design Issues]

posted by jag009  – NJ, 2013-10-25 07:12 (4625 d 02:59 ago) – Posting: # 11763
Views: 8,415

Hi Mittyri,

❝ Nathan Teuscher does not explain a type of trial. So I'm interested in opinion of the colleagues who are working with BEQ protocols.


His conclusion was based on AUC being similar between the two sampling time schemes which I agree. For BE studies we need to determine both AUC and Cmax equivalence between test and reference. Therefore the PK time point selection is important (if not critical).

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
114 visitors (0 registered, 114 guests [including 15 identified bots]).
Forum time: 10:11 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5